Merck Recalls Temodar and Temozolomide Bottles with Cracked Caps Due to Failure to Meet Child-Resistant Closure Requirement
CPSC Recall1 injuries · 2015-08-18 · 15219
Hazards
The bottle cap can be cracked which can cause the child-resistant closure to become ineffective to young children who can gain unintended access to the capsules, posing a risk of poisoning.
Recall
Number
15219
Date
2015-08-18
Injuries reported
1
Products
Names
Bottles with cracked caps containing Temodar® (Temozolomide) and Temozolomide (generic) capsules
Remedies
Options
Replace
Companies
Manufacturer(s)
Merck Sharp & Dohme Corp., of Whitehouse Station, N.J.
Retailer(s)
Clinics and pharmacies nationwide as a prescribed medicine from July 2013 to August 2015. The container was included in the cost of the medication which is based on quantities prescribed, health insurance terms and other factors.
Country of manufacture
United States
Description
This recall to replace involves bottle caps for Temodar and Temozolomide (generic) capsules, an oral chemotherapy drug. The capsules were distributed in 5- and 14-count brown glass bottles that have white plastic child-resistant caps. A white label affixed to the bottle has the word "Temozolomide" printed in black lettering.